Press Release September 28, 2021Merck (MRK) Dips More Than Broader Markets: What You Should Know 0 0 Share
Company Ticker News September 27, 2021Merck's Keytruda Tops Placebo On Overall Survival Endpoint In Liver Cancer Patients 0 0 Share
Press Release September 24, 2021LYNPARZA® (olaparib) in Combination With Abiraterone Significantly Delayed Disease Progression in Patients Regardless of Biomarker Status in PROpel Phase 3 Trial in First-Line Metastatic Castration-Resistant Prostate Cancer (mCRPC) 0 0 Share
Press Release September 23, 2021Nektar (NKTR) Signs Deals With Pfizer, Merck KGaA for NKTR-255 0 0 Share
Press Release September 21, 2021Nektar, Merck Germany, Pfizer Join Forces For Mid-Stage Bladder Cancer Study 0 0 Share
Company Ticker News September 21, 2021Merck (MRK) Keytruda Gets CHMP Nod for Severe Breast Cancer 0 0 Share
Company Ticker News September 21, 2021Merck (MRK) Gains As Market Dips: What You Should Know 0 0 Share
